Aerie shares rock­et up as glau­co­ma com­bo drug scores pos­i­tive da­ta

Shares of Aerie Phar­ma­ceu­ti­cals $AERI sky­rock­et­ed on promis­ing da­ta for a com­bi­na­tion glau­co­ma drug that best­ed its own late-stage drug Rho­pres­sa by adding a well …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER